Full Text
REGD. No. D. L.-33004/99
The Gazette of India
CG-DL-E-28022024-252472
EXTRAORDINARY
PART II—Section 3—Sub-section (ii)
PUBLISHED BY AUTHORITY
No. 894]
NEW DELHI, WEDNESDAY, FEBRUARY 28, 2024/PHALGUNA 9, 1945
1365 GI/2024
MINISTRY OF CHEMICALS AND FERTILIZERS
(Department of Pharmaceuticals)
(NATIONAL PHARMACEUTICAL PRICING AUTHORITY)
ORDER
New Delhi, the 28th February, 2024
S.O. 937(E).—In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control)
Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 5249(E) dated 11th November, 2022 issued
by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing
Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below
as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the
corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing
company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;
TABLE
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| SI. | Name of the Formulation / | Strength | Unit | Manufacturer & | Retail |
| No. | Brand Name | | | Marketing | Price |
| | | | | Company | (Rs.) |
+=====+=================================================+=================================================+===============+=================================================+================+
| (1) | (2) | (3) | (4) | (5) | (6) |
+=====+=================================================+=================================================+===============+=================================================+================+
| 1 | Sitagliptin and Metformin | Each film coated tablet | 1 Tablet | M/s Synokem | 13.25 |
| | Hydrochloride Extended | contains: | | Pharmaceuticals Ltd. | |
| | Release Tablets | Sitagliptin Phosphate | | / M/s Mankind | |
| | | Monohydrate IP eq. to | | Pharma Ltd. | |
| | | Sitagliptin 100mg | | | |
| | | Metformin Hydrochloride IP | | | |
| | | 1000mg (As extended release) | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 2 | Olmesartan Medoxomil, | Each film coated tablet | 1 Tablet | M/s Pure and Cure | 8.92 |
| | Amlodipine | contains: | | Healthcare Pvt. Ltd. / | |
| | &HydrochlorothiazideTablet | Olmesartan Medoxomil IP 20mg | | M/s Blue Cross | |
| | | Amlodipine Besilate IP eq. to | | Laboratories Private | |
| | | Amlodipine 5mg | | Limited | |
| | | Hydrochlorothiazide IP 12.5mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 3 | Olmesartan Medoxomil, | Each film coated tablet | 1 Tablet | M/s Pure and Cure | 10.71 |
| | Amlodipine | contains: | | Healthcare Pvt. Ltd. / | |
| | &HydrochlorothiazideTablet | Olmesartan Medoxomil IP 40mg | | M/s Blue Cross | |
| | | Amlodipine Besilate IP eq. to | | Laboratories Private | |
| | | Amlodipine 5mg | | Limited | |
| | | Hydrochlorothiazide IP 12.5mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 4 | Telmisartan, Amlodipine & | Each film coated tablet | 1 Tablet | M/s Pure and Cure | 16.24 |
| | Hydrochlorothiazide Tablet | contains: | | Healthcare Pvt. Ltd. / | |
| | | Telmisartan IP 80mg | | M/s Mankind Pharma | |
| | | Amlodipine Besilate IP eq. to | | Ltd. | |
| | | Amlodipine 5mg | | | |
| | | Hydrochlorothiazide IP 12.5mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 5 | Paracetamol, Phenylephrine | Each 5ml contains: | 1 ml | M/s Mascot Health | 1.06 |
| | HCl & Chlorpheniramine | Paracetamol IP 125mg | | Series Pvt. Ltd. / M/s | |
| | Maleate Syrup | Phenylephrine HCl IP 5.0mg | | Biological E. Limited | |
| | | Chlorpheniramine Maleate IP | | | |
| | | 1.0mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 6 | Phenylephrine | Each 5ml contains: | 1 ml | M/s Windlas Biotech | 1.22 |
| | Hydrochloride and | Phenylephrine Hydrochloride IP | | Limited / M/s | |
| | Chlorpheniramine Maleate | 5.0mg | | Biological E. Limited | |
| | Syrup | Chlorpheniramine Maleate IP | | | |
| | | 2.0mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 7 | Chlorpheniramine Maleate, | Each 5ml contains: | 1 ml | M/s Yacca | 0.94 |
| | Dextromethorphan | Chlorpheniramine Maleate IP | | Lifesciences Pvt. Ltd. | |
| | Hydrobromide & | 2mg | | / M/s German | |
| | Phenylephrine | Phenylephrine Hydrochloride IP | | Remedies | |
| | Hydrochloride Syrup | 5mg | | Pharmaceuticals | |
| | | Dextromethorphan | | Private Limited | |
| | | Hydrobromide IP 15mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 8 | Escitalopram Oxalate | Each film coated tablet | 1 Tablet | M/s Lupin Limited | 11.84 |
| | Tablets | contains: | | | |
| | | Escitalopram Oxalate IP eq. to | | | |
| | | Escitalopram 15mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 9 | Amoxycillin and Potassium | Each 5ml of reconstituted | 1 ml | M/s Brooks | 4.22 |
| | Clavulanate Oral Suspension | suspension contains: | | Laboratories Ltd. / | |
| | | Amoxycillin Trihydrate IP eq. to | | M/s German | |
| | | Amoxycillin 400mg | | Remedies | |
| | | Potassium Clavulanate Diluted IP | | Pharmaceuticals | |
| | | eq. to Clavulanic Acid 57mg | | Private Limited | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 10 | Cefixime and Ofloxacin | Each film coated tablet | 1 Tablet | M/s Aagya Biotech | 13.87 |
| | Tablets | contains: | | Pvt. Ltd. / M/s | |
| | | Cefixime IP (As Trihydrate) eq. | | German Remedies | |
| | | to Anhydrous Cefixime 200mg | | Pharmaceuticals | |
| | | Ofloxacin IP 200mg | | Private Limited | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 11 | Paracetamol Paediatric Oral | Each 1ml contains: | 1 ml | M/s Aristo | 1.62 |
| | Suspension | Paracetamol IP 100mg | | Pharmaceuticals Pvt. | |
| | | | | Ltd. | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 12 | Chlorpheniramine Maleate, | Each 5ml contains: | 1 ml | M/s Yacca | 0.99 |
| | Dextromethorphan | Chlorpheniramine Maleate IP | | Lifesciences Pvt. Ltd. | |
| | Hydrobromide & | 2mg | | / M/s German | |
| | Phenylephrine | Phenylephrine Hydrochloride IP | | Remedies | |
| | Hydrochloride Syrup | 5mg | | Pharmaceuticals | |
| | | Dextromethorphan | | Private Limited | |
| | | Hydrobromide IP 10mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 13 | Clopidogrel & Aspirin | Each uncoated bilayered tablet | 1 Tablet | M/s Skymap | 4.85 |
| | Tablets | contains: | | Pharmaceuticals Pvt. | |
| | | Clopidogrel Bisulphate IP eq. to | | Ltd./M/s German | |
| | | Clopidogrel 75mg | | Remedies | |
| | | Aspirin IP 150mg | | Pharmaceuticals | |
| | | | | Private Limited | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 14 | Meropenem and Sulbactum | Each vial contains: | 1 Vial | M/s Skymap | 1598.75 |
| | for Injection | Meropenem IP eq. to Anhydrous | | Pharmaceuticals Pvt. | |
| | | Meropenem 1000mg (A Sterile | | Ltd./M/s German | |
| | | Mixture of meropenem & | | Remedies | |
| | | Sodium Carbonate (Sodium | | Pharmaceuticals | |
| | | 90.2mg) | | Private Limited | |
| | | Sulbactam Sodium IP eq. to | | | |
| | | Anhydrous Sulbactum 500mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 15 | Olmesartan Medoxomil, | Each film coated tablet | 1 Tablet | M/s Skymap | 14.52 |
| | Hydrochlorothiazide & | contains: | | Pharmaceuticals Pvt. | |
| | Amlodipine Tablet | Olmesartan Medoxomil IP 20mg | | Ltd./M/s German | |
| | | Hydrochlorothiazide IP 12.5mg | | Remedies | |
| | | Amlodipine Besilate IP eq. to | | Pharmaceuticals | |
| | | Amlodipine 5mg | | Private Limited | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 16 | Cefpodoxime & Potassium | Each 5ml reconstituted | 1 ml | M/s Saitech | 3.10 |
| | Clavulanate Oral suspension | suspension contains: | | Medicare Pvt. Ltd. / | |
| | | Cefpodoxime Proxetil IP eq. to | | M/s German | |
| | | Anhydrous Cefpodoxime 50mg | | Remedies | |
| | | Potassium Clavulanate Diluted IP | | Pharmaceuticals | |
| | | eq. to Clavulanic Acid 31.25mg | | Private Limited | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 17 | Cefuroxime Axetil& | Each film coated tablet | 1 Tablet | M/s Saitech | 56.98 |
| | Potassium Clavulanate | contains: | | Medicare Pvt. Ltd. / | |
| | Tablets | Cefuroxime Axetil IP eq. to | | M/s German | |
| | | Cefuroxime 500mg | | Remedies | |
| | | Potassium Clavulanate Diluted IP | | Pharmaceuticals | |
| | | eq. to Clavulanic Acid 125mg | | Private Limited | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 18 | Telmisartan & | Each uncoated bi-layer tablet | 1 Tablet | M/s Aristo | 17.74 |
| | Chlorthalidone Tablet | contains: | | Pharmaceuticals Pvt. | |
| | | Telmisartan IP 80mg | | Ltd. | |
| | | Chlorthalidone 6.25mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 19 | Trypsin, Bromelain, | Each enteric coated tablet | 1 Tablet | M/s Synokem | 21.80 |
| | Rutoside Trihydrate and | contains: | | Pharmaceutical Ltd./ | |
| | Diclofenac Sodium Tablets | Trypsin BP 48mg | | M/s Intas | |
| | | Bromelain 90mg | | Pharmaceuticals Ltd. | |
| | | Rutoside Trihydrate BP 100mg | | | |
| | | Diclofenac Sodium IP 50mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 20 | Montelukast and | Each uncoated bilayered tablet | 1 Tablet | M/s Pure and Cure | 17.54 |
| | Acebrophylline (SR) Tablets | contains: | | Healthcare Pvt. Ltd. / | |
| | | Montelukast Sodium IP eq. to | | M/s Apex | |
| | | Montelukast 10mg | | Laboratories Private | |
| | | Acebrophylline 200mg (As | | Limited | |
| | | sustained release) | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 21 | Atorvastatin and Fenofibrate | Each film coated tablet | 1 Tablet | M/s Skymap | 15.93 |
| | Tablets | contains: | | Pharmaceuticals Pvt. | |
| | | Atorvastatin Calcium IP eq. to | | Ltd./M/s German | |
| | | Atorvastatin 10mg | | Remedies | |
| | | Fenofibrate IP 160mg | | Pharmaceuticals | |
| | | | | Private Limited | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 22 | Calcium & Vitamins Tablet | Each film coated tablet | 1 Tablet | M/s Premier | 18.87 |
| | | contains: | | Nutraceuticals Pvt. | |
| | | Calcium Carbonate IP (From | | Ltd./M/s Zuventus | |
| | | Coral Grains) eq. to Elemental | | Healthcare Limited | |
| | | Calcium 500mg | | | |
| | | Vitamin D3 IP (As Stabilised) | | | |
| | | 2000 IU | | | |
| | | Methylcobalamin IP 1500mcg | | | |
| | | L-Methylfolate Calcium USP | | | |
| | | 1mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 23 | Cefpodoxime & Potassium | Each film coated tablet | 1 Tablet | M/s Saitech | 28.49 |
| | Clavulanate Tablets | contains: | | Medicare Pvt. Ltd. / | |
| | | Cefpodoxime Proxetil IP eq. to | | M/s German | |
| | | Anhydrous Cefpodoxime 200mg | | Remedies | |
| | | Potassium Clavulanate Diluted IP | | Pharmaceuticals | |
| | | eq. to Clavulanic Acid 125mg | | Private Limited | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 24 | Levetiracetam Extended- | Each film coated Extended- | 1 Tablet | M/s Akums Drugs & | 33.37 |
| | release Tablets | release tablet contains: | | Pharmaceuticals Ltd. | |
| | | Levetiracetam IP 1000mg | | / M/s Cipla Ltd. | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 25 | Aceclofenac and | Each film coated tablet contains: | 1 Tablet | M/s Stedman | 5.14 |
| | Paracetamol tablets | Aceclofenac IP 100mg | | Pharmaceuticals Pvt. | |
| | | Paracetamol IP 325mg | | Ltd. | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 26 | Linagliptin and Metformin | Each film coated tablet | 1 Tablet | M/s Skymap | 8.56 |
| | Hydrochloride Tablet | contains: | | Pharmaceuticals Pvt. | |
| | | Linagliptin 2.5mg | | Ltd./M/s German | |
| | | Metformin Hydrochloride IP | | Remedies | |
| | | 500mg | | Pharmaceuticals | |
| | | | | Private Limited | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 27 | Paracetamol, Phenylephrine | Each uncoated tablet contains: | 1 Tablet | M/s Akums Drugs | 3.57 |
| | HCl & Chlorpheniramine | Paracetamol IP 500mg | | and Pharmaceuticals | |
| | Maleate Tablets | Phenylephrine HCl IP 10mg | | Ltd./ M/s Blue Cross | |
| | | Chlorpheniramine Maleate IP | | Laboratories Private | |
| | | 2mg | | Limited | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 28 | Moxifloxacin hydrochloride | Composition: | 1 ml | M/s Skymap | 23.27 |
| | & | Moxifloxacin hydrochloride IP | | Pharmaceuticals Pvt. | |
| | Dexamethasone Phosphate | eq. to Moxifloxacin 0.5%w/v | | Ltd./M/s German | |
| | Eye Drops | Dexamethasone Sodium | | Remedies | |
| | | Phosphate IP eq. to | | Pharmaceuticals | |
| | | Dexamethasone Phosphate 0.1% | | Private Limited | |
| | | w/v | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 29 | Trypsin-Chymotrypsin, | Each Film Coated Tablet | 1 Tablet | M/s Synokem | 14.21 |
| | Paracetamol and | contains: | | Pharmaceuticals Ltd. | |
| | Aceclofenac Tablets | 150000 Armour Units Enzymatic | | / M/s Troikaa | |
| | | Activity (Supplied By a Purified | | Pharmaceuticals | |
| | | Concentrate Which Has Specific | | Limited | |
| | | Trypsin & Chymotrypsin Activity | | | |
| | | In a Ratio Of Approximately Six | | | |
| | | To One) (As Enteric Coated | | | |
| | | Granules) | | | |
| | | Paracetamol IP 325 mg | | | |
| | | Aceclofenac IP 100 mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 30 | Chlorpheniramine Maleate | Each 5ml contains: | 1 ml | M/s Akums Drugs & | 1.22 |
| | & Phenylephrine | Chlorpheniramine Maleate IP | | Pharmaceuticals Ltd. | |
| | Hydrochloride Syrup | 2mg | | / M/s Apex | |
| | | Phenylephrine Hydrochloride IP | | Laboratories Private | |
| | | 5mg | | Limited | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 31 | Vildagliptin and Metformin | Each film coated tablet | 1 Tablet | M/s Skymap | 8.43 |
| | Hydrochloride Tablet | contains: | | Pharmaceuticals Pvt. | |
| | | Vildagliptin IP 50mg | | Ltd./M/s German | |
| | | Metformin Hydrochloride IP | | Remedies | |
| | | 1000mg | | Pharmaceuticals | |
| | | | | Private Limited | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 32 | Vildagliptin and Metformin | Each film coated tablet | 1 Tablet | M/s Skymap | 8.04 |
| | Hydrochloride Tablet | contains: | | Pharmaceuticals Pvt. | |
| | | Vildagliptin IP 50mg | | Ltd. / M/s German | |
| | | Metformin Hydrochloride IP | | Remedies | |
| | | 500mg | | Pharmaceuticals | |
| | | | | Private Limited | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 33 | Sitagliptin Phosphate and | Each film coated tablet | 1 Tablet | M/s Skymap | 9.13 |
| | Metformin Hydrochloride | contains: | | Pharmaceuticals Pvt. | |
| | tablets | Sitagliptin Phosphate | | Ltd./M/s German | |
| | | Monohydrate IP eq. to Sitagliptin | | Remedies | |
| | | 50mg | | Pharmaceuticals | |
| | | Metformin Hydrochloride IP | | Private Limited | |
| | | 500mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 34 | Sitagliptin Phosphate and | Each film coated tablet | 1 Tablet | M/s Skymap | 10.39 |
| | Metformin Hydrochloride | contains: | | Pharmaceuticals Pvt. | |
| | tablets | Sitagliptin Phosphate | | Ltd./M/s German | |
| | | Monohydrate IP eq. to Sitagliptin | | Remedies | |
| | | 50mg | | Pharmaceuticals | |
| | | Metformin Hydrochloride IP | | Private Limited | |
| | | 1000mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 35 | Methylcobalamin, Alpha | Each film coated tablet | 1 Tablet | M/s Pure and Cure | 8.03 |
| | Lipoic Acid, Vitamin D3, | contains: | | Healthcare Pvt. Ltd. / | |
| | Pyridoxine Hydrochloride & | Methylcobalamin IP 1500mcg | | M/s Blue Cross | |
| | Folic Acid Tablets | Alpha Lipoic Acid IP 100mg | | Laboratories Private | |
| | | Vitamin D3 IP 1000IU | | Limited | |
| | | Pyridoxine Hydrochloride IP 3mg | | | |
| | | Folic Acid IP 1.5mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 36 | Tranexamic Tablets | Each film coated tablet | 1 Tablet | M/s Emcure | 30.06 |
| | | contains: | | Pharmaceuticals | |
| | | Tranexamic Acid IP 1000mg | | Limited | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 37 | Ceftriaxone and Tazobactam | Each combi pack contains: | 1 Vial | M/s East African | 189.45 |
| | injection | Part-I | | (India) Overseas / | |
| | | Ceftriaxone and Tazobactam for | | M/s Softdeal | |
| | | Injection 1125mg | | Pharmaceuticals | |
| | | Each vial contains: | | Private Limited | |
| | | Ceftriaxone Sodium IP (Sterile) | | | |
| | | eq. to Ceftriaxone 1gm, | | | |
| | | Tazobactam Sodium IP (Sterile) | | | |
| | | eq. to Tazobactam 125mg | | | |
| | | Part-II | | | |
| | | (For Reconstitution) | | | |
| | | Each FFS | | | |
| | | Ampoule contains: | | | |
| | | Sterile Water for Injection IP | | | |
| | | 10ml | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 38 | Telmisartan & Cilnidipine | Each film coated bilayered | 1 Tablet | M/s Windlas Biotech | 10.39 |
| | Tablet | tablet contains: | | Ltd. (Plant 2) / M/s | |
| | | Telmisartan IP 40mg | | Emcure | |
| | | Cilnidipine IP 10mg | | Pharmaceuticals | |
| | | | | Limited | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 39 | Diclofenac Sodium & | Each uncoated tablet contains: | 1 Tablet | M/s Pure and Cure | 4.99 |
| | Paracetamol Tablets | Diclofenac Sodium IP 50mg, | | Healthcare Pvt. Ltd. / | |
| | | Paracetamol IP 325mg | | M/s Softdeal | |
| | | | | Pharmaceuticals | |
| | | | | Private Limited | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 40 | Vitamin D3 | Each ml contains: | 1 ml | M/s SAF Fermion | 5.53 |
| | (Cholecalciferol) Oral Drops | Vitamin D3 (Cholecalciferol) | | Limited | |
| | | 800IU | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 41 | Telmisartan & | Each film coated tablet | 1 Tablet | M/s Akums Drugs | 5.35 |
| | Chlorthalidone Tablet | contains: | | and Pharmaceuticals | |
| | | Telmisartan IP 40mg | | Ltd. / M/s Blue Cross | |
| | | Chlorthalidone 6.25mg | | Laboratories Pvt. | |
| | | | | Ltd. | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 42 | Telmisartan & | Each film coated tablet | 1 Tablet | M/s Akums Drugs | 6.25 |
| | Chlorthalidone Tablet | contains: | | and Pharmaceuticals | |
| | | Telmisartan IP 40mg | | Ltd. / M/s Blue Cross | |
| | | Chlorthalidone 12.50mg | | Laboratories Pvt. | |
| | | | | Ltd. | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 43 | Itraconazole Capsules | Each hard gelatin capsule | 1 Capsule | M/s Synokem | 19.50 |
| | 130mg (Supra- Bioavailable | contains: | | Pharmaceuticals Ltd. | |
| | Formulation) | Itraconazole BP 130mg | | / M/s Aristo | |
| | | | | Pharmaceuticals Pvt. | |
| | | | | Ltd. | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 44 | Linagliptin, Metformin | Each film coated bilayered | 1 Tablet | M/s Mascot Health | 13.03 |
| | Hydrochloride (Extended | tablet contains: | | Series Pvt. Ltd. / M/s | |
| | Release) Tablets | Linagliptin 5mg | | Torrent | |
| | | Metformin Hydrochloride IP | | Pharmaceuticals Ltd. | |
| | | 500mg (As Extended Release) | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 45 | Linagliptin, Metformin | Each film coated bilayered | 1 Tablet | M/s Synokem | 14.65 |
| | Hydrochloride (Extended | tablet contains: | | Pharmaceuticals | |
| | Release) Tablets | Linagliptin 5mg | | Limited / M/s | |
| | | Metformin Hydrochloride IP | | Mankind Pharma | |
| | | 1000mg (As Extended Release) | | Limited | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 46 | Dapagliflozin, Metformin | Each film coated bilayered | 1 Tablet | M/s Mascot Health | 14.65 |
| | Hydrochloride (Extended | tablet contains: | | Series Pvt. Ltd. / M/s | |
| | Release) and Glimepiride | Dapagliflozin Propanediol USP | | Eris Lifesciences | |
| | Tablets | eq. to Dapagliflozin 10mg | | Limited | |
| | | Metformin Hydrochloride IP | | | |
| | | 1000mg (As Extended release) | | | |
| | | Glimepiride IP 1 mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 47 | Dapagliflozin, Metformin | Each film coated bilayered | 1 Tablet | M/s Mascot Health | 14.44 |
| | Hydrochloride (Extended | tablet contains: | | Series Pvt. Ltd. / M/s | |
| | Release) and Glimepiride | Dapagliflozin Propanediol USP | | Mankind Pharma | |
| | Tablets | eq. to Dapagliflozin 10mg | | Ltd. | |
| | | Metformin Hydrochloride IP | | | |
| | | 1000mg (As Extended release) | | | |
| | | Glimepiride IP 1 mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 48 | Dapagliflozin, Metformin | Each film coated bilayered | 1 Tablet | M/s Mascot Health | 14.65 |
| | Hydrochloride (Extended | tablet contains: | | Series Pvt. Ltd. / M/s | |
| | Release) and Glimepiride | Dapagliflozin Propanediol USP | | Alkem Laboratories | |
| | Tablets | eq. to Dapagliflozin 10mg | | Limited | |
| | | Metformin Hydrochloride IP | | | |
| | | 1000mg (As Extended release) | | | |
| | | Glimepiride IP 1 mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 49 | Dapagliflozin, Metformin | Each film coated bilayered | 1 Tablet | M/s Mascot Health | 14.65 |
| | Hydrochloride (Extended | tablet contains: | | Series Pvt. Ltd. / M/s | |
| | Release) and Glimepiride | Dapagliflozin Propanediol USP | | Torrent | |
| | Tablets | eq. to Dapagliflozin 10mg | | Pharmaceuticals | |
| | | Metformin Hydrochloride IP | | Limited | |
| | | 1000mg (As Extended release) | | | |
| | | Glimepiride IP 1 mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 50 | Dapagliflozin, Metformin | Each film coated bilayered | 1 Tablet | M/s Mascot Health | 14.44 |
| | Hydrochloride (Extended | tablet contains: | | Series Pvt. Ltd. / M/s | |
| | Release) and Glimepiride | Dapagliflozin Propanediol USP | | Lupin Limited | |
| | Tablets | eq. to Dapagliflozin 10mg | | | |
| | | Metformin Hydrochloride IP | | | |
| | | 1000mg (As Extended release) | | | |
| | | Glimepiride IP 1 mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 51 | Dapagliflozin, Metformin | Each film coated bilayered | 1 Tablet | M/s Mascot Health | 14.44 |
| | Hydrochloride (Extended | tablet contains: | | Series Pvt. Ltd. / M/s | |
| | Release) and Glimepiride | Dapagliflozin Propanediol USP | | Medley | |
| | Tablets | eq. to Dapagliflozin 10mg | | Pharmaceuticals Ltd. | |
| | | Metformin Hydrochloride IP | | | |
| | | 1000mg (As Extended release) | | | |
| | | Glimepiride IP 1 mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 52 | Dapagliflozin, Metformin | Each film coated bilayered | 1 Tablet | M/s Mascot Health | 16.33 |
| | Hydrochloride (Extended | tablet contains: | | Series Pvt. Ltd. / M/s | |
| | Release) and Glimepiride | Dapagliflozin Propanediol USP | | Eris Lifesciences | |
| | Tablets | eq. to Dapagliflozin 10mg | | Limited | |
| | | Metformin Hydrochloride IP | | | |
| | | 1000mg (As Extended release) | | | |
| | | Glimepiride IP 2 mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 53 | Dapagliflozin, Metformin | Each film coated bilayered | 1 Tablet | M/s Mascot Health | 16.12 |
| | Hydrochloride (Extended | tablet contains: | | Series Pvt. Ltd. / M/s | |
| | Release) and Glimepiride | Dapagliflozin Propanediol USP | | Mankind Pharma | |
| | Tablets | eq. to Dapagliflozin 10mg | | Ltd. | |
| | | Metformin Hydrochloride IP | | | |
| | | 1000mg (As Extended release) | | | |
| | | Glimepiride IP 2 mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 54 | Dapagliflozin, Metformin | Each film coated bilayered | 1 Tablet | M/s Mascot Health | 16.33 |
| | Hydrochloride (Extended | tablet contains: | | Series Pvt. Ltd. / M/s | |
| | Release) and Glimepiride | Dapagliflozin Propanediol USP | | Alkem Laboratories | |
| | Tablets | eq. to Dapagliflozin 10mg | | Limited | |
| | | Metformin Hydrochloride IP | | | |
| | | 1000mg (As Extended release) | | | |
| | | Glimepiride IP 2 mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 55 | Dapagliflozin, Metformin | Each film coated bilayered | 1 Tablet | M/s Mascot Health | 16.33 |
| | Hydrochloride (Extended | tablet contains: | | Series Pvt. Ltd. / M/s | |
| | Release) and Glimepiride | Dapagliflozin Propanediol USP | | Torrent | |
| | Tablets | eq. to Dapagliflozin 10mg | | Pharmaceuticals | |
| | | Metformin Hydrochloride IP | | Limited | |
| | | 1000mg (As Extended release) | | | |
| | | Glimepiride IP 2 mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 56 | Dapagliflozin, Metformin | Each film coated bilayered | 1 Tablet | M/s Mascot Health | 16.12 |
| | Hydrochloride (Extended | tablet contains: | | Series Pvt. Ltd. / M/s | |
| | Release) and Glimepiride | Dapagliflozin Propanediol USP | | Lupin Limited | |
| | Tablets | eq. to Dapagliflozin 10mg | | | |
| | | Metformin Hydrochloride IP | | | |
| | | 1000mg (As Extended release) | | | |
| | | Glimepiride IP 2 mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 57 | Dapagliflozin, Metformin | Each film coated bilayered | 1 Tablet | M/s Mascot Health | 16.12 |
| | Hydrochloride (Extended | tablet contains: | | Series Pvt. Ltd. / M/s | |
| | Release) and Glimepiride | Dapagliflozin Propanediol USP | | Medley | |
| | Tablets | eq. to Dapagliflozin 10mg | | Pharmaceuticals Ltd. | |
| | | Metformin Hydrochloride IP | | | |
| | | 1000mg (As Extended release) | | | |
| | | Glimepiride IP 2 mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 58 | Sitagliptin Phosphate, | Each film coated tablet | 1 Tablet | M/s Exemed | 12.00 |
| | Metformin Hydrochloride | contains: | | Pharmaceuticals / | |
| | and Glimepiride Tablets | Sitagliptin Phosphate | | M/s Cipla Ltd. | |
| | | Monohydrate IP eq. to Sitagliptin | | | |
| | | 50mg | | | |
| | | Metformin Hydrochloride IP | | | |
| | | 1000mg | | | |
| | | Glimepiride IP 1 mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 59 | Sitagliptin Phosphate, | Each film coated tablet | 1 Tablet | M/s Synokem | 13.35 |
| | Metformin Hydrochloride | contains: | | Pharmaceuticals Ltd. | |
| | and Glimepiride Tablets | Sitagliptin Phosphate | | /M/s Alkem | |
| | | Monohydrate IP eq. to Sitagliptin | | Laboratories Limited | |
| | | 50mg | | | |
| | | Metformin Hydrochloride IP | | | |
| | | 1000mg | | | |
| | | Glimepiride IP 1 mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 60 | Sitagliptin Phosphate, | Each film coated tablet | 1 Tablet | M/s Synokem | 13.00 |
| | Metformin Hydrochloride | contains: | | Pharmaceuticals Ltd. | |
| | and Glimepiride Tablets | Sitagliptin Phosphate | | /M/s Intas | |
| | | Monohydrate IP eq. to Sitagliptin | | Pharmaceuticals Ltd. | |
| | | 50mg | | | |
| | | Metformin Hydrochloride IP | | | |
| | | 1000mg | | | |
| | | Glimepiride IP 1 mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 61 | Sitagliptin Phosphate, | Each film coated tablet | 1 Tablet | M/s Exemed | 14.00 |
| | Metformin Hydrochloride | contains: | | Pharmaceuticals / | |
| | and Glimepiride Tablets | Sitagliptin Phosphate | | M/s Cipla Ltd. | |
| | | Monohydrate IP eq. to Sitagliptin | | | |
| | | 50mg | | | |
| | | Metformin Hydrochloride IP | | | |
| | | 1000mg | | | |
| | | Glimepiride IP 2 mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 62 | Sitagliptin Phosphate, | Each film coated tablet | 1 Tablet | M/s Synokem | 15.03 |
| | Metformin Hydrochloride | contains: | | Pharmaceuticals Ltd. | |
| | and Glimepiride Tablets | Sitagliptin Phosphate | | /M/s Alkem | |
| | | Monohydrate IP eq. to Sitagliptin | | Laboratories Limited | |
| | | 50mg | | | |
| | | Metformin Hydrochloride IP | | | |
| | | 1000mg | | | |
| | | Glimepiride IP 2 mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 63 | Sitagliptin Phosphate, | Each film coated tablet | 1 Tablet | M/s Synokem | 15.00 |
| | Metformin Hydrochloride | contains: | | Pharmaceuticals Ltd. | |
| | and Glimepiride Tablets | Sitagliptin Phosphate | | /M/s Intas | |
| | | Monohydrate IP eq. to Sitagliptin | | Pharmaceuticals Ltd. | |
| | | 50mg | | | |
| | | Metformin Hydrochloride IP | | | |
| | | 1000mg | | | |
| | | Glimepiride IP 2 mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 64 | Dapagliflozin, Metformin | Each film coated bilayered | 1 Tablet | M/s Mascot Health | 13.24 |
| | Hydrochloride (Extended | tablet contains: | | Series Pvt. Ltd. / M/s | |
| | Release) and Glimepiride | Dapagliflozin Propanediol USP | | Torrent | |
| | Tablets | eq. to Dapagliflozin 10mg | | Pharmaceuticals | |
| | | Metformin Hydrochloride IP | | Limited | |
| | | 500mg (As Extended release) | | | |
| | | Glimepiride IP 1 mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 65 | Dapagliflozin, Metformin | Each film coated bilayered | 1 Tablet | M/s Mascot Health | 14.75 |
| | Hydrochloride (Extended | tablet contains: | | Series Pvt. Ltd. / M/s | |
| | Release) and Glimepiride | Dapagliflozin Propanediol USP | | Torrent | |
| | Tablets | eq. to Dapagliflozin 10mg | | Pharmaceuticals | |
| | | Metformin Hydrochloride IP | | Limited | |
| | | 500mg (As Extended release) | | | |
| | | Glimepiride IP 2 mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 66 | Dapagliflozin, Metformin | Each film coated bilayered | 1 Tablet | M/s Mascot Health | 14.92 |
| | Hydrochloride (Extended | tablet contains: | | Series Pvt. Ltd. / M/s | |
| | Release) and Glimepiride | Dapagliflozin Propanediol USP | | Alkem Laboratories | |
| | Tablets | eq. to Dapagliflozin 10mg | | Limited | |
| | | Metformin Hydrochloride IP | | | |
| | | 500mg (As Extended release) | | | |
| | | Glimepiride IP 2 mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 67 | Trypsin, Bromelain, | Each enteric coated tablet | 1 Tablet | M/s Synokem | 21.80 |
| | Rutoside Trihydrate and | contains: | | Pharmaceuticals | |
| | Diclofenac Sodium Tablets | Trypsin BP 48mg | | Limited / M/s Neon | |
| | | Bromelain 90mg | | Laboratories Limited | |
| | | Rutoside Trihydrate BP 100mg | | | |
| | | Diclofenac Sodium IP 50mg | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 68 | Diclofenac Diethylamine, | Composition: | 1 gram | M/s Pontika | 3.12 |
| | Methyl Salicylate & | Diclofenac Diethylamine IP | | Aerotech Limited / | |
| | Menthol Topical Spray | 2.32% w/w (eq. to Diclofenac | | M/s Cadila | |
| | | Sodium 2% w/w), | | Pharmaceuticals Ltd. | |
| | | Methyl Salicylate IP 10% w/w, | | | |
| | | Menthol IP 5% w/w | | | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
| 69 | Tranexamic Acid Tablet | Each film coated tablet | 1 Tablet | M/s Pure and Cure | 18.43 |
| | | contains: | | Healthcare Pvt. Ltd. / | |
| | | Tranexamic Acid IP 250mg | | M/s Sun | |
| | | | | Pharmaceutical | |
| | | | | Industries Limited | |
+-----+-------------------------------------------------+-------------------------------------------------+---------------+-------------------------------------------------+----------------+
Note:
(a) The manufacturer of above-mentioned formulations i.e., "new drug" under paragraph 2(1)(u) of the DPCO,
2013 shall fix the retail price as specified in column (6) of the table hereinabove.
(b) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the
Government on the retail price mentioned in column (6) of the above said table.
(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in
accordance with the retail price specified in column (6) of the above table as per provisions contained in
paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form-V from date of
Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State
Drug Controller and dealers.
(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary
price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on
business in a manner so as to be easily accessible to any person wishing to consult the same.
(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned
above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated
under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the
Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent
Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned
manufacturer/marketing companies.
(f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price
notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be
liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO,
2013 read with the Essential Commodities Act, 1955.
(g) Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table
with the strength and name of Manufacturer & Marketing Companies specified in the corresponding entries
in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified
strength for that Manufacturer & Marketing Companies as specified in corresponding entries in Column (2),
(3) and (5) thereof, if any, issued prior to this notification, stand(s) superseded.
[PN/253/121/2024/F/ F. No. 8(121)/2024/D.P./NPPA-Div.-II]
MAHAVEER SAINI, Dy. Director (Pricing)
ORDER
New Delhi, the 28th February, 2024
S.O. 938(E).— In exercise of the powers conferred by paragraphs 4, 6, 10, 11, 14, 16, 17 and 18 of the Drugs
(Prices Control) Order, 2013, read with S.O. 1394(E) dated 30th May, 2013 and S.O. 5249(E) dated 11th November,
2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order of
the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) No
SO 1573(E) dated 31st March, 2023 & S.O. 4663(E) dated 25.10.2023 in so far as it relates to formulation packs
mentioned in the table below, except in respect of things done or omitted to be done before such supersession, the
National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the price as specified in
column (5) of the table herein below as ceiling price exclusive of goods and services tax applicable, if any, in respect
of the Scheduled formulation specified in the corresponding entry in column (2) of the said Table with the dosage
form & strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof:
TABLE
+-----+---------------------------------------+---------------------------------------------+---------------+----------------+
| Sl. | Name of the Scheduled | Dosage form and strength | Unit | Ceiling Price |
| No. | Formulation | | | (Rs.) |
+=====+=======================================+=============================================+===============+================+
| (1) | (2) | (3) | (4) | (5) |
+=====+=======================================+=============================================+===============+================+
| 1 | Zidovudine | Tablet 300mg | 1 Tablet | 13.59 |
+-----+---------------------------------------+---------------------------------------------+---------------+----------------+
| 2 | Benzathine | Powder for Injection 12 lac units | 1 Vial | 19.81 |
| | benzylpenicillin | | | |
+-----+---------------------------------------+---------------------------------------------+---------------+----------------+
| 3 | Folic Acid | Capsule 5 mg | 1 Capsule | 5.04 |
+-----+---------------------------------------+---------------------------------------------+---------------+----------------+
| 4 | Fentanyl | Injection 50mcg/mL | 1 ML | 20.96 |
+-----+---------------------------------------+---------------------------------------------+---------------+----------------+
| 5 | Benzathine
Login to read full text